Cargando…
e-Pharmacophore modeling and in silico study of CD147 receptor against SARS-CoV-2 drugs
Coronavirus has left severe health impacts on the human population, globally. Still a significant number of cases are reported daily as no specific medications are available for its effective treatment. The presence of the CD147 receptor (human basigin) on the host cell facilitates the severe acute...
Autores principales: | Pandit, Nisha Kumari, Mann, Simranjeet Singh, Mohanty, Anee, Meena, Sumer Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326537/ https://www.ncbi.nlm.nih.gov/pubmed/37415452 http://dx.doi.org/10.5808/gi.23005 |
Ejemplares similares
-
A critical review on biogas production from edible and non-edible oil cakes
por: Mohanty, Anee, et al.
Publicado: (2021) -
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021) -
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis
por: Wu, Jiao, et al.
Publicado: (2022) -
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
por: Shilts, Jarrod, et al.
Publicado: (2021) -
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
por: Ragotte, Robert J., et al.
Publicado: (2021)